@article{99f9115ac6364f2db3b240a59eae75f1,
title = "Retinal Pigment Deposition Secondary to Iatrogenic Pigment Dispersion",
author = "Rowlands, {Megan A.} and Kaden, {Talia R.} and Weiss, {Michael J.} and Dedania, {Vaidehi S.} and Lee, {Gregory D.} and Schuman, {Joel S.} and Haberman, {Ilyse D.} and Schiff, {William M.} and Modi, {Yasha S.}",
note = "Funding Information: Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article. Financial Disclosure(s): The author(s) have made the following disclosure(s): V.S.D.: Consultant – Allergan. J.S.S.: Consultant – Ocugenix, LLC, Annexon, Inc, Shire Pharmaceuticals, Pfizer, Slack Inc/Vindico Medical Education, Alcon Laboratories, Aerie; Financial support — Slack, Inc, Vindico Medical Education, Alcon Laboratories, Aerie, Zeiss; Advisory Board — Opticent Health, IOP Medical Ltd; Equity owner — Ocugenix, LLC, Opticent Health and IOP Medical Ltd.; Royalties — Zeiss Optical, Elsevier, University of Pittsburgh, Massachusetts Eye and Ear Infirmary. Obtained funding: N/A",
year = "2019",
month = jun,
doi = "10.1016/j.oret.2018.12.005",
language = "English (US)",
volume = "3",
pages = "536--538",
journal = "Ophthalmology Retina",
issn = "2468-7219",
publisher = "Elsevier Inc.",
number = "6",
}